Hospitals & Diagnostics · Hospital/Nursing Management · NSE: SHALBY · data 2026-10-30
Shalby Ltd.
In plain words
Price: 52.1% below its 52-week high of ₹252.05.
Delivery: 59.9% of traded shares were kept for delivery over the last 10 sessions, against 56.7% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹1,176 cr |
| Net profit (last 12 months) | ₹39 cr |
| Sales growth, 3 years (yearly) | 12.3% |
| Profit growth, 3 years (yearly) | -18.0% |
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 57.2% over the last 20 sessions vs 57.2% in the 40 before (1x); shares delivered per day 0.8x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
Is Shalby Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.59.
What is Shalby Ltd.'s P/E ratio?
About 32.8, based on the last 12 months' earnings and a price of ₹120.64 (data 2026-10-30).
What is the 52-week high and low of Shalby Ltd.?
The 52-week high is ₹252.05 and the 52-week low is ₹110.61.
Similar companies
Indraprastha Medical Corporation Limited (INDRAMEDCO) · KMC Speciality Hospitals (India) Limited (KMCSHIL) · Gujarat Kidney & Super Speciality Ltd. (GKSL) · GPT Healthcare Limited (GPTHEALTH) · KRM Ayurveda Ltd. (KRMAYURVED)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open SHALBY in NSE Scanner →